Use of split intein and myotropic AAV vectors enables effective preclinical gene therapy for dysferlinopathy. (science.org)

Authors: McCormack NM … Tasfaout H Journal: Science Translational Medicine Published: 2026-10-07 DOI: https://doi.org/10.1126/scitranslmed.aei5938